Optimizing treatment selection and timing of allogeneic haematopoietic stem cell transplantation in acute myeloid leukaemia with concurrent feline McDonough sarcoma (FMS)‐like tyrosine kinase 3 internal tandem duplication, nucleophosmin 1 and deoxyribonucleic acid (DNA) methyltransferase 3 alpha mutations

Documenti analoghi

• Author reply to McDonough
  di: Brendan J. Nolan, et al.
  Pubblicazione: (2025)
• Maintenance therapy with the FMS‐like tyrosine kinase 3 inhibitor gilteritinib in patients with FMS‐like tyrosine kinase 3–internal tandem duplication acute myeloid leukemia: A phase 2 study
  di: Emmanuel Gyan, et al.
  Pubblicazione: (2025)
• Immunophenotypic characterisation of acute myeloid leukaemia with UBTF tandem duplications
  di: Sean Harrop, et al.
  Pubblicazione: (2024)
• Clinical and genetic profiles and outcomes of allogeneic haematopoietic stem cell transplantation in secondary myelodysplastic syndrome following aplastic anaemia
  di: Jia Li, et al.
  Pubblicazione: (2024)
• The Efficacy and Safety of the Addition of Mitoxantrone Hydrochloride Liposome in Conditioning Regimen for High‐Risk Acute Myeloid Leukemia
  di: Xiaoyu Zhang, et al.
  Pubblicazione: (2025)